Jane Henney

From Wikispooks
Revision as of 00:19, 30 July 2022 by Terje (talk | contribs) (unstub)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Person.png Jane Henney  Rdf-entity.pngRdf-icon.png
(physician, civil servant)
Jane Henney.jpg
Born1947
NationalityUS
Alma materManchester University (Indiana), Indiana University School of Medicine, University of Texas MD Anderson Cancer Center
InterestsStatins
Commissioner of the U.S. Food and Drug Administration who joined the pharmaceutical company AstraZeneca's board of directors.

Employment.png Commissioner of the U.S. Food and Drug Administration

In office
17 January 1999 - 19 January 2001
Appointed byBill Clinton
After leaving the FDA she joined the AstraZeneca board of directors

Jane Ellen Henney is an American physician who was commissioner of the U.S. Food and Drug Administration. Appointed by President Bill Clinton, she had the job at the FDA from 1999 to 2001. After leaving the FDA she joined the pharmaceutical company AstraZeneca's board of directors.

Education and career

Jane Henney was born in Woodburn, Indiana. She received her undergraduate training at Manchester University, an MD degree from Indiana University School of Medicine and did postgraduate work at the University of Texas MD Anderson Cancer Center in Houston. Trained as a medical oncologist, she joined the National Cancer Institute at the National Institutes of Health in 1976, working in the Cancer Therapy and Evaluation Program.

Prior to her appointment as commissioner, Henney had worked at the FDA from 1992 to 1994 as deputy commissioner for operations under then-commissioner David Aaron Kessler, and then at the University of New Mexico, where she was vice president of the health sciences center. After leaving the FDA she joined the board of directors of the pharmaceutical company AstraZeneca.

A significant and far reaching decision by the FDA under her tenure, was the ban on supplements and natural products that contain lovastatin, effectively handing exclusivity of cholesterol lowering compounds to pharmaceutical companies. AstraZeneca benefited directly from this decision this removed a cheap, natural product, from competing with their own statin rosuvastatin.

She was named senior vice president and provost for health affairs at the University of Cincinnati in 2003.


Many thanks to our Patrons who cover ~2/3 of our hosting bill. Please join them if you can.


References

Wikipedia.png This page imported content from Wikipedia on 07.07.2022.
Wikipedia is not affiliated with Wikispooks.   Original page source here